Cargando…

Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CL(pro), Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach

Background: Since the first patient identified with SARS-CoV-2 symptoms in December 2019, the trend of a spreading coronavirus disease 2019 (COVID-19) infection has remained to date. As for now, there is an urgent need to develop novel drugs or vaccines for the SARS-CoV-2 virus. Methods: Polyphenoli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arokiyaraj, Selvaraj, Stalin, Antony, Kannan, Balakrishnan Senthamarai, Shin, Hakdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761775/ https://www.ncbi.nlm.nih.gov/pubmed/33287311 http://dx.doi.org/10.3390/antibiotics9120863

Ejemplares similares

Anti-methanogenic effect of rhubarb (Rheum spp.) – An in silico docking studies on methyl-coenzyme M reductase (MCR)
por: Arokiyaraj, Selvaraj, et al.
Publicado: (2019)

Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition
por: Choi, Jang-Gi, et al.
Publicado: (2019)

Chemical composition, antioxidant activity and antibacterial mechanism of action from Marsilea minuta leaf hexane: methanol extract
por: Arokiyaraj, Selvaraj, et al.
Publicado: (2018)

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021)

Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL(pro)
por: Vincent, Savariar, et al.
Publicado: (2020)

Fabrication of anti-bacterial cotton bandage using biologically synthesized nanoparticles for medical applications
por: Senthamarai Kannan, Monika, et al.
Publicado: (2022)

Neohesperidin and spike RBD interaction in omicron and its sub-variants: In silico, structural and simulation studies
por: Singh, Jaikee Kumar, et al.
Publicado: (2023)

Artemisia herba-alba sesquiterpenes: in silico inhibition in the ATP-binding pocket
por: Mohamed, Tarik A., et al.
Publicado: (2023)

The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II
por: Chen, Meixia, et al.
Publicado: (2016)

Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach
por: Avelar, Mayra, et al.
Publicado: (2023)

In silico identification of RBD subdomain of spike protein from Pro(322)-Thr(581) for applications in vaccine development against SARS-CoV2
por: Pagadala, Nataraj S, et al.
Publicado: (2021)

In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro))
por: Vergoten, Gérard, et al.
Publicado: (2021)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
por: Budhraja, Anshul, et al.
Publicado: (2021)

Herba Cistanches: Anti-aging
por: Wang, Ningqun, et al.
Publicado: (2017)

Researches on the preparation and characterization of some tinctures from Silene albae herba and Silene pendulae herba
por: Tircomnicu, Viorela, et al.
Publicado: (2012)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach
por: Akachar, Jihane, et al.
Publicado: (2020)

In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
por: Nag, Anish, et al.
Publicado: (2021)

Evaluation of flavonoids as potential inhibitors of the SARS-CoV-2 main protease and spike RBD: Molecular docking, ADMET evaluation and molecular dynamics simulations
por: Hadni, Hanine, et al.
Publicado: (2022)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike
por: Banerjee, Amrita, et al.
Publicado: (2022)

Cistanches Herba: A Neuropharmacology Review
por: Gu, Caimei, et al.
Publicado: (2016)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
por: BR, Bharath, et al.
Publicado: (2020)

Targeting CoV-2 spike RBD and ACE-2 interaction with flavonoids of Anatolian propolis by in silico and in vitro studies in terms of possible COVID-19 therapeutics
por: GÜLER, Halil İbrahim, et al.
Publicado: (2021)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)

In silico Mapping of Protein Unfolding Mutations for Inherited Disease
por: McCafferty, Caitlyn L., et al.
Publicado: (2016)

Inhibition of SARS-CoV-2 main protease 3CL(pro) by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking
por: Elzupir, Amin O.
Publicado: (2020)

Study on the Antinociceptive Effects of Herba Epimedium in Mice
por: Sun, Jiang-hong, et al.
Publicado: (2015)

Analgesic alkaloids from Urticae Fissae Herba
por: Feng, Xiaoru, et al.
Publicado: (2021)

Studies on Cistanches Herba: A Bibliometric Analysis
por: Wu, Longjiang, et al.
Publicado: (2023)

QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro))
por: Taranto, Alex G., et al.
Publicado: (2008)

Quantitative in silico analysis of SARS-CoV-2 S-RBD omicron mutant transmissibility
por: Hanai, Toshihiko
Publicado: (2022)

SARS-CoV-2 main protease (3CL(pro)) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking
por: Mohandoss, Sonaimuthu, et al.
Publicado: (2022)

Tenofovir antiviral drug solubility enhancement with β-cyclodextrin inclusion complex and in silico study of potential inhibitor against SARS-CoV-2 main protease (M(pro))
por: Mohandoss, Sonaimuthu, et al.
Publicado: (2023)

In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches
por: Sahayarayan, Jesudass Joseph, et al.
Publicado: (2021)

Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells
por: De March, Matteo, et al.
Publicado: (2022)

Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
por: Passariello, Margherita, et al.
Publicado: (2021)

SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
por: Miao, Lu, et al.
Publicado: (2023)

Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein
por: Vetráková, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ua9o9n81hv9p8lfs5v19s850ah